| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 |
| Phrase | Consultant | Town | Special Interests |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological oncology, prostate cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, endocrine resistance in breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma, soft tissue sarcoma, bone sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, rare cancers, head and neck cancers, sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, palliative care, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, genetic testing, oncogenetics |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, carcinoma of unknown primary, acute oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancers, BRCA mutations, gynaecological cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, early and advanced breast cancer, role of novel therapies for cancer, novel targets in familial breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, kidney cancer, melanoma, skin cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, clinical trials, experimental therapies |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, HIV related cancers, brain cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, immunotherapy, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, viral gene therapy, ovarian cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, gastrointestinal malignancy, advanced bowel cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, immunotherapy, targeted therapy, cancer biomarkers, drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, cancer genetics, genetic oncology, pharmacogenomics, breast cancer, ovarian cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, bile duct cancer, bowel (colon and rectum) cancer, liver cancer, oesophageal cancer, pancreatic cancer, gastrointestinal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, education and training |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, clinical oncology, upper and lower gastrointestinal malignancies, urological cancers, oesophageal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal cancer, germ cell tumours, neuroendocrine tumours |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, acute oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, rectal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, primary brain cancers |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, cancer genomics |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, renal cancer, melanoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, acute oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, carcinoma of unknown primary |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological cancer, clinical trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, mesothelioma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast imaging |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lymphoma, high dose chemotherapy with stem cell support, HIV associated malignancy, lymphoproliferative disorders |
| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 |
